{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T01:12:33Z","timestamp":1785114753141,"version":"3.55.0"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T00:00:00Z","timestamp":1585612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004350","name":"Studienstiftung des Deutschen Volkes","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004350","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002839","name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002839","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.00531","type":"journal-article","created":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T12:28:36Z","timestamp":1585657716000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":34,"title":["Tumor-Derived Extracellular Vesicles Impair CD171-Specific CD4+ CAR T Cell Efficacy"],"prefix":"10.3389","volume":"11","author":[{"given":"Solin","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Toews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Schwiebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anika","family":"Klaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Winkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Grunewald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Oevermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hedwig E.","family":"Deubzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"T\u00fcns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton G.","family":"Henssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Eggert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes H.","family":"Schulte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Schwich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Rebmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Schramm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"K\u00fcnkele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,3,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/978-1-4614-8051-8_11","article-title":"Immunotherapies in CLL","volume":"792","author":"Park","year":"2013","journal-title":"Adv Exp Med Biol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1056\/NEJMoa1103849","article-title":"Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia","volume":"365","author":"Porter","year":"2011","journal-title":"N Engl J Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","article-title":"Chimeric antigen receptor T cells for sustained remissions in leukemia","volume":"371","author":"Maude","year":"2014","journal-title":"N Engl J Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"4817","DOI":"10.1182\/blood-2011-04-348540","article-title":"Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias","volume":"118","author":"Brentjens","year":"2011","journal-title":"Blood."},{"key":"B5","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S0140-6736(14)61403-3","article-title":"T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial","volume":"385","author":"Lee","year":"2015","journal-title":"Lancet."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.3389\/fimmu.2017.01850","article-title":"Chimeric antigen receptors T cell therapy in solid tumor: challenges and clinical applications","volume":"8","author":"Mirzaei","year":"2017","journal-title":"Front Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1007\/s11427-016-5025-6","article-title":"Treatment of solid tumors with chimeric antigen receptor-engineered T cells: current status and future prospects","volume":"59","author":"Di","year":"2016","journal-title":"Sci China Life Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nat Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1172\/JCI81136","article-title":"Exosomes and tumor-mediated immune suppression","volume":"126","author":"Whiteside","year":"2016","journal-title":"J Clin Invest."},{"key":"B10","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s12307-015-0167-9","article-title":"Exosomes secreted from human cancer cell lines contain inhibitors of apoptosis (IAP)","volume":"8","author":"Valenzuela","year":"2015","journal-title":"Cancer Microenviron."},{"key":"B11","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3389\/fimmu.2016.00173","article-title":"The potential of HLA-G-bearing extracellular vesicles as a future element in HLA-G immune biology","volume":"7","author":"Rebmann","year":"2016","journal-title":"Front Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.humimm.2016.01.002","article-title":"The prognostic impact of soluble and vesicular HLA-G and its relationship to circulating tumor cells in neoadjuvant treated breast cancer patients","volume":"77","author":"Konig","year":"2016","journal-title":"Hum Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s41586-018-0392-8","article-title":"Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response","volume":"560","author":"Chen","year":"2018","journal-title":"Nature."},{"key":"B14","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.cell.2019.02.016","article-title":"Suppression of exosomal PD-L1 induces systemic anti-tumor immunity and memory","volume":"177","author":"Poggio","year":"2019","journal-title":"Cell."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1053\/j.sempedsurg.2011.10.009","article-title":"Neuroblastoma","volume":"21","author":"Davidoff","year":"2012","journal-title":"Semin Pediatr Surg."},{"key":"B16","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrc1014","article-title":"Neuroblastoma: biological insights into a clinical enigma","volume":"3","author":"Brodeur","year":"2003","journal-title":"Nat Rev Cancer."},{"key":"B17","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1056\/NEJM199303253281205","article-title":"Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma","volume":"328","author":"Nakagawara","year":"1993","journal-title":"N Engl J Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1093\/jnci\/85.5.377","article-title":"Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas","volume":"85","author":"Suzuki","year":"1993","journal-title":"J Natl Cancer Inst."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1158\/0008-5472.CAN-12-0556","article-title":"Expression of the neurotrophin receptor TrkA down-regulates expression and function of angiogenic stimulators in SH-SY5Y neuroblastoma cells","volume":"62","author":"Eggert","year":"2002","journal-title":"Cancer Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1016\/S0959-8049(97)00266-9","article-title":"Activation of trk-A but not trk-B signal transduction pathway inhibits growth of neuroblastoma cells","volume":"33","author":"Lucarelli","year":"1997","journal-title":"Eur J Cancer."},{"key":"B21","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1002\/ijc.28096","article-title":"Expression of NTRK1\/TrkA affects immunogenicity of neuroblastoma cells","volume":"133","author":"Pajtler","year":"2013","journal-title":"Int J Cancer."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1016\/j.dnarep.2008.07.004","article-title":"Expression of the TrkA or TrkB receptor tyrosine kinase alters the double-strand break (DSB) repair capacity of SY5Y neuroblastoma cells","volume":"7","author":"Schulte","year":"2008","journal-title":"DNA Repair."},{"key":"B23","first-page":"6462","article-title":"Resistance to chemotherapy mediated by TrkB in neuroblastomas","volume":"62","author":"Ho","year":"2002","journal-title":"Cancer Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1128\/MCB.14.1.759","article-title":"Expression and function of TRK-B and BDNF in human neuroblastomas","volume":"14","author":"Nakagawara","year":"1994","journal-title":"Mol Cell Biol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1158\/2326-6066.CIR-14-0200","article-title":"Functional tuning of CARs reveals signaling threshold above which CD8+ CTL antitumor potency is attenuated due to cell Fas-FasL-dependent AICD","volume":"3","author":"Kunkele","year":"2015","journal-title":"Cancer Immunol Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1158\/1078-0432.CCR-16-0354","article-title":"Preclinical assessment of CD171-directed CAR T-cell adoptive therapy for childhood neuroblastoma: CE7 epitope target safety and product manufacturing feasibility","volume":"23","author":"Kunkele","year":"2017","journal-title":"Clin Cancer Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1055\/s-2000-9677","article-title":"Prognostic and biological role of neurotrophin-receptor TrkA and TrkB in neuroblastoma","volume":"212","author":"Eggert","year":"2000","journal-title":"Klin Padiatr."},{"key":"B28","doi-asserted-by":"publisher","first-page":"26913","DOI":"10.3402\/jev.v3.26913","article-title":"Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles","volume":"3","author":"Lotvall","year":"2014","journal-title":"J Extracell Vesicles."},{"key":"B29","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.colsurfb.2011.05.013","article-title":"Characterisation of exosomes derived from human cells by nanoparticle tracking analysis and scanning electron microscopy","volume":"87","author":"Sokolova","year":"2011","journal-title":"Colloids Surf B Biointerfaces."},{"key":"B30","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.canlet.2005.02.051","article-title":"Biological effects of TrkA and TrkB receptor signaling in neuroblastoma","volume":"228","author":"Schramm","year":"2005","journal-title":"Cancer Lett."},{"key":"B31","first-page":"32","article-title":"Production of CGMP-grade lentiviral vectors","volume":"10","author":"Ausubel","year":"2012","journal-title":"Bioprocess Int."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1038\/gt.2010.91","article-title":"Adoptive immunotherapy with genetically engineered T cells: modification of the IgG1 Fc \u201cspacer\u201d domain in the extracellular moiety of chimeric antigen receptors avoids \u201coff-target\u201d activation and unintended initiation of an innate immune response","volume":"17","author":"Hombach","year":"2010","journal-title":"Gene Ther."},{"key":"B33","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.semcdb.2015.02.009","article-title":"Exosomes and their roles in immune regulation and cancer","volume":"40","author":"Greening","year":"2015","journal-title":"Semin Cell Dev Biol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"eaar2766","DOI":"10.1126\/sciadv.aar2766","article-title":"Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles","volume":"4","author":"Ricklefs","year":"2018","journal-title":"Sci Adv."},{"key":"B35","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/sj.onc.1208000","article-title":"Microarray analysis reveals differential gene expression patterns and regulation of single target genes contributing to the opposing phenotype of TrkA- and TrkB-expressing neuroblastomas","volume":"24","author":"Schulte","year":"2005","journal-title":"Oncogene."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1038\/nm.1882","article-title":"Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma","volume":"14","author":"Pule","year":"2008","journal-title":"Nat Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e1261243","DOI":"10.1080\/2162402X.2016.1261243","article-title":"Human tumor-derived exosomes (TEX) regulate Treg functions via cell surface signaling rather than uptake mechanisms","volume":"6","author":"Muller","year":"2017","journal-title":"Oncoimmunology."},{"key":"B38","doi-asserted-by":"publisher","first-page":"20254","DOI":"10.1038\/srep20254","article-title":"Tumor-derived exosomes regulate expression of immune function-related genes in human T cell subsets","volume":"6","author":"Muller","year":"2016","journal-title":"Sci Rep."},{"key":"B39","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1158\/1078-0432.1010.11.3","article-title":"Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes","volume":"11","author":"Kim","year":"2005","journal-title":"Clin Cancer Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s40425-017-0269-7","article-title":"Tumor-derived exosomes induce CD8(+) T cell suppressors","volume":"5","author":"Maybruck","year":"2017","journal-title":"J Immunother Cancer."},{"key":"B41","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1158\/2326-6066.CIR-17-0113","article-title":"Exosomes associated with human ovarian tumors harbor a reversible checkpoint of T-cell responses","volume":"6","author":"Shenoy","year":"2018","journal-title":"Cancer Immunol Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s00018-014-1764-3","article-title":"Formation and role of exosomes in cancer","volume":"72","author":"Brinton","year":"2015","journal-title":"Cell Mol Life Sci."},{"key":"B43","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/1096-911X(20010101)36:1<181::AID-MPO1043>3.0.CO;2-Q","article-title":"Effect of CEP-751 (KT-6587) on neuroblastoma xenografts expressing TrkB","volume":"36","author":"Evans","year":"2001","journal-title":"Med Pediatr Oncol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1056\/NEJMoa1714448","article-title":"Efficacy of larotrectinib in TRK fusion-positive cancers in adults and children","volume":"378","author":"Drilon","year":"2018","journal-title":"N Engl J Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"44179","DOI":"10.18632\/oncotarget.6175","article-title":"Therapeutic potential of CAR-T cell-derived exosomes: a cell-free modality for targeted cancer therapy","volume":"6","author":"Tang","year":"2015","journal-title":"Oncotarget."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00531\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T01:53:48Z","timestamp":1666230828000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00531\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,31]]},"references-count":45,"alternative-id":["10.3389\/fimmu.2020.00531"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.00531","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,31]]},"article-number":"531"}}